Eisler Capital (UK)’s AbbVie ABBV Stock Holding History

Eisler Capital (UK)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-8,227	Closed	-$1.54M	–	565
2024 Q2	$1.41M	Buy	8,227 +2,447	+42%	+$405K	0.01%	425
2024 Q1	$1.05M	Sell	5,780 -22,173	-79%	-$3.82M	0.01%	511
2023 Q4	$4.33M	Buy	27,953 +25,585	+1,080%	+$3.73M	0.03%	321
2023 Q3	$353K	Buy	+2,368	New	+$348K	﹤0.01%	435
2022 Q1	–	Sell	-11,866	Closed	-$1.72M	–	495
2021 Q4	$1.61M	Buy	+11,866	New	+$1.4M	0.08%	172

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Eisler Capital (UK)'s ABBV Position: Q3 2024 in Review

Eisler Capital (UK) sold out of AbbVie (ABBV) in Q3 2024, closing a stake of 8,227 shares — an estimated $1.54M sold.

Eisler Capital (UK) first reported a position in ABBV in Q4 2021 and held it in 5 quarters. The position peaked at $4.33M in Q4 2023. 3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

Eisler Capital (UK) reported no remaining AbbVie position as of Q3 2024 after selling out during the quarter.
Eisler Capital (UK) sold 8,227 AbbVie shares in Q3 2024, an estimated $1.54M.
Eisler Capital (UK) first reported a position in AbbVie in Q4 2021 and held it in 5 quarters.
Eisler Capital (UK)'s AbbVie position peaked at $4.33M in Q4 2023.
3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on Eisler Capital (UK)'s 13F filing for Q3 2024, filed 14 Nov 2024.